PurCann Pharma

PurCann Pharma is proud to announce its participation in a study evaluating the potential efficacy of cannabinoids to relieve the symptoms of multiple sclerosis.

This year, the conference will once again bring together several players in the cannabis industry from Canada and even Europe, from different fields such as science, R&D, politics and the medical field.

Important news for PurCann Pharma and Groupe SiliCycle : PurCann Pharma has completed the acquisition of Neptune Wellness Solutions’ cannabis division!

On May 19th, the scientific conference of the year dedicated to cannabis, organized by PurCann Pharma, took place in Quebec City

A TV crew from Noovo Info visited PurCann Pharma’s facilities, and shot a report that presents the company and its ambitions

From October 20th to 22nd, come and meet PurCann Pharma at MJBizCon 2021, the largest global event dedicated to the cannabis industry!

On the occasion of Expo Cannabis Montreal, PurCann Pharma unveiled its two new product lines: Ollopa and Oovie

On September 14th and 15th, 2021, PurCann Pharma will attend to the major event dedicated to the Cannabis industry in Quebec

QUEBEC CITY, July 14, 2021 – SiliCycle Inc., a company working in the health field, founded and established in Quebec City, takes a major step by announcing that it has obtained its retail license for cannabis products, topical products, cannabis extracts and edibles from Health Canada. It is with the contribution of its subsidiary PurCann Pharma and under …

Purcann Pharma now benefits from a cannabis products retail sale license Read More »

Purcann Pharma has been selected as a finalist in the “Innovation | Life Sciences” category by ADRIQ (Quebec Association for the Development of Research and Innovation)